-
1
-
-
0034741193
-
Marqueurs biologiques: Biomarqueurs - Utilisation au cours du développement et pour l'enregistrement des médicaments
-
Gueyffier F, Dib M, Boissel JP. Marqueurs biologiques: biomarqueurs - utilisation au cours du développement et pour l'enregistrement des médicaments. Thérapie 2001; 56: 355-61
-
(2001)
Thérapie
, vol.56
, pp. 355-361
-
-
Gueyffier, F.1
Dib, M.2
Boissel, J.P.3
-
2
-
-
0031174157
-
Evaluation clinique: Du critère intermédiaire au critère de substitution
-
Boissel JP, Perret L, Bouvenot G, et al. Evaluation clinique: du critère intermédiaire au critère de substitution. Therapie 1997; 52: 281-5
-
(1997)
Therapie
, vol.52
, pp. 281-285
-
-
Boissel, J.P.1
Perret, L.2
Bouvenot, G.3
-
3
-
-
0024520844
-
Surrogate endpoints in clinical trials: Definition and operational criteria
-
Prentice RL. Surrogate endpoints in clinical trials: definition and operational criteria. Stat Med 1989; 8 (4): 431-40
-
(1989)
Stat Med
, vol.8
, Issue.4
, pp. 431-440
-
-
Prentice, R.L.1
-
4
-
-
0026593243
-
Serum cholesterol, blood pressure, cigarette smoking, and death from coronary heart disease. Overall findings and differences by age for 316,099 white men: Multiple Risk Factor Intervention Trial Research Group
-
Jan
-
Neaton JD, Wentworth D. Serum cholesterol, blood pressure, cigarette smoking, and death from coronary heart disease. Overall findings and differences by age for 316,099 white men: Multiple Risk Factor Intervention Trial Research Group. Arch Intern Med 1992 Jan; 152 (1): 56-64
-
(1992)
Arch Intern Med
, vol.152
, Issue.1
, pp. 56-64
-
-
Neaton, J.D.1
Wentworth, D.2
-
5
-
-
0034686717
-
Relationship of baseline serum cholesterol levels in 3 large cohorts of younger men to long-term coronary, cardiovascular, and all-cause mortality and to longevity
-
Stamler J, Daviglus ML, Garside DB, et al. Relationship of baseline serum cholesterol levels in 3 large cohorts of younger men to long-term coronary, cardiovascular, and all-cause mortality and to longevity. JAMA 2000; 284: 311-31
-
(2000)
JAMA
, vol.284
, pp. 311-331
-
-
Stamler, J.1
Daviglus, M.L.2
Garside, D.B.3
-
6
-
-
0026795925
-
Report of the Conference on low blood cholesterol: Mortality associations
-
Jacobs D, Blackburn H, Higgins M, et al. Report of the Conference on low blood cholesterol: mortality associations. Circulation 1992; 86: 1046-60
-
(1992)
Circulation
, vol.86
, pp. 1046-1060
-
-
Jacobs, D.1
Blackburn, H.2
Higgins, M.3
-
7
-
-
0027380992
-
Cholesterol reduction and the risk for stroke in men: A meta-analysis of randomized, controlled trials
-
Atkins D, Psaty BM, Koepsell TD. Cholesterol reduction and the risk for stroke in men: a meta-analysis of randomized, controlled trials. Ann Intern Med 1993; 119: 136-45
-
(1993)
Ann Intern Med
, vol.119
, pp. 136-145
-
-
Atkins, D.1
Psaty, B.M.2
Koepsell, T.D.3
-
8
-
-
0028181730
-
By how much and how quickly does reduction in serum cholesterol concentration lower risk of ischaemic heart disease?
-
Law MR, Wald NJ, Thompson SG. By how much and how quickly does reduction in serum cholesterol concentration lower risk of ischaemic heart disease? BMJ 1994; 308: 367-72
-
(1994)
BMJ
, vol.308
, pp. 367-372
-
-
Law, M.R.1
Wald, N.J.2
Thompson, S.G.3
-
9
-
-
0028845911
-
Reduction in cardiovascular events during pravastatin therapy: Pooled analysis of clinical events of the Pravastatin Atherosclerosis Intervention Program
-
Byington RP, Jukema JW, Salonen JT, et al. Reduction in cardiovascular events during pravastatin therapy: pooled analysis of clinical events of the Pravastatin Atherosclerosis Intervention Program. Circulation 1995; 92: 2419-25
-
(1995)
Circulation
, vol.92
, pp. 2419-2425
-
-
Byington, R.P.1
Jukema, J.W.2
Salonen, J.T.3
-
10
-
-
0037066048
-
Relationship between lipid levels and clinical outcomes in the long-term Intervention with pravastatin in ischemic disease (LIPID) trial: To what extent is the reduction in coronary events with pravastatin explained by on-Study lipid levels?
-
Simes RJ, Marschner IC, Hunt D, et al. Relationship between lipid levels and clinical outcomes in the long-term Intervention with pravastatin in ischemic disease (LIPID) trial: to what extent is the reduction in coronary events with pravastatin explained by on-Study lipid levels? Circulation 2002; 105: 1162-9
-
(2002)
Circulation
, vol.105
, pp. 1162-1169
-
-
Simes, R.J.1
Marschner, I.C.2
Hunt, D.3
-
11
-
-
17044448335
-
Mechanisms of action of statins and their pleiotropic effects
-
Davignon J, Mabile L. Mechanisms of action of statins and their pleiotropic effects. Ann Endocrinol 2001; 62: 101-12
-
(2001)
Ann Endocrinol
, vol.62
, pp. 101-112
-
-
Davignon, J.1
Mabile, L.2
-
12
-
-
85031163914
-
Bénéfice clinique des traitements hypocholestérolémiants: Méta-analyse des essais thérapeutiques randomisés
-
Cucherat M, Lièvre M, Gueyffier F. Bénéfice clinique des traitements hypocholestérolémiants: méta-analyse des essais thérapeutiques randomisés. Presse Méd 2000; 29: 565-76
-
(2000)
Presse Méd
, vol.29
, pp. 565-576
-
-
Cucherat, M.1
Lièvre, M.2
Gueyffier, F.3
-
13
-
-
0037031061
-
MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: A randomised placebo-controlled trial
-
Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebo-controlled trial. Lancet 2002; 360: 7-22
-
(2002)
Lancet
, vol.360
, pp. 7-22
-
-
-
14
-
-
0027987849
-
Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S)
-
The Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 1994; 344: 1383-9
-
(1994)
Lancet
, vol.344
, pp. 1383-1389
-
-
-
15
-
-
0032513878
-
Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: Principal results of the Hypertension Optimal Treatment (HOT) randomised trial
-
HOT Study Group
-
Hansson L, Zanchetti A, Carruthers SG, et al. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group. Lancet 1998; 35: 1755-62
-
(1998)
Lancet
, vol.35
, pp. 1755-1762
-
-
Hansson, L.1
Zanchetti, A.2
Carruthers, S.G.3
-
16
-
-
0037193819
-
Risk factor thresholds: Their existence under scrutiny
-
Law MR, Wald NJ. Risk factor thresholds: their existence under scrutiny. BMJ 2002; 324: 1570-6
-
(2002)
BMJ
, vol.324
, pp. 1570-1576
-
-
Law, M.R.1
Wald, N.J.2
|